Human Hepatitis B Virus (HBV) RNAs contain a cis-acting sequence, the post-transcriptional regulatory element (HPRE), which facilitates the cytoplasmic localization of intronless transcripts. Our previous studies have shown that the HPRE is composed of at least two independent sub-elements, HPREα and HPREβ, which co-activate a reporter for RNA export in a greater than additive manner. Utilizing deletion, mutation and co-variational analyses, we have identified three regions important for full HPRE activity. The three separate regions of the HPRE function can function independently in a dose-dependent manner when multimerized. Two of these regions contain stem loops, HSLα and HSLβ1, which are necessary for full HPRE function. These structures are conserved throughout the mammalian Hepadnaviruses. Disruption of either stem-loop structure by mutagenesis decreases HPRE function while compensatory mutations restore activity. The location of the stem-loops in the genome reveal that they are present in all of the HBV transcripts. HSLα and HSLβ1 are likely to contain the binding sites for the cellular factor(s) which mediates HPRE function.
INTRODUCTION
The Human Hepatitis B Virus (HBV) is a partially double stranded circular DNA virus (1) which replicates via reverse transcription (2) (3) (4) . The 3.2 kb genome has four open reading frames which encode the polymerase, surface, core and X proteins (2, (5) (6) (7) (8) (9) . These four transcripts originate from different promoters, but utilize the same polyadenylation site contained within a common 3′-terminus (10, 11) (Fig. 1) . The viral RNAs are intronless and are exported from the nucleus unspliced (12) (13) (14) .
Several cis-elements regulate the expression of viral proteins. Two enhancers, enhancer I (EnhI) and enhancer II (EnhII), modulate transcription of HBV RNAs in a primarily liver-specific manner (15, 16) . HBV also contains an orientation-dependent RNA element which facilitates the cytoplasmic localization of viral RNAs. This element, the HBV post-transcriptional regulatory element (HPRE), has been shown to be required for efficient expression of the HBV surface protein (17) (18) (19) and is at least partially contained in all the viral genomic and coding transcripts (20) (Fig. 1) . Previous studies of the HPRE have revealed a complex structure consisting of at least two independent sub-elements, HPREα and HPREβ, which co-activate a reporter for RNA export in a greater than additive manner (20, 21) . The sub-elements are proposed to contain binding sites for a cellular protein(s) which mediates function (17, 18, 20, 21) . We have recently identified a PRE in Woodchuck Hepatitis Virus (WHV) (22) .
The mechanism of HPRE function has been partially explored. The HPRE has been shown to act post-transcriptionally (17, 18) . The HPRE is functional whether it is in an intron-containing or intronless context (17, 19) . It can also function to activate the cytoplasmic accumulation of intron containing RNA in an exonic position (19, 20) . These data indicate that a direct role in splicing is unlikely. The HPRE has also been shown not to have a pronounced effect on RNA half-life (17, 18) . A direct export mechanism has been proposed (19, 23) . This mechanism would shunt the mRNAs into an export pathway, similar to the different pathways proposed for HIV-1 Rev. and the constitutive transport element (CTE) of Mason-Pfizer monkey virus (MPMV) (24) (25) (26) . Export of Hepatitis B mRNAs can be inhibited by nuclear export signal (NES) containing proteins (23) , however, HPRE mediated export is leptomycin B (LMB) insensitive, indicating that the HPRE pathway is different than the CRM1-dependent Rev. pathway (27) . Determination of the mechanism of HPRE function will rely on further analysis of the HPRE and identification of cellular proteins which mediate activity.
Here we present a structural characterization of the HPRE. Using phylogenetic covariation, computer folding and deletion analysis, key structural RNA components within HPREα and HPREβ were identified. The structures are a 30 nt imperfect RNA stem-loop formed by nucleotides 1292-1321 (HPRE stem-loop α or HSLα) and a 30 nt stem-loop formed by nucleotides 1408-1437 (HPRE stem-loop β or HSLβ1). Mutational analysis of these structures reveal that they are required for full HPRE export function. Additionally, minimal fragments containing HSLα and HSLβ1 which encompass nucleotides 1278-1340 and 1347-1457 are shown to be sufficient for function. These data indicate that the function of the PRE is mediated through secondary structure elements (stem-loops) which may act as binding sites for a cellular protein(s) which is necessary for the function of the HPRE. 
MATERIALS AND METHODS

Plasmids
pDM138 has been previously described (28) . p138HPRE2, containing nucleotides 1151-1582 of HBV, was constructed by ligating a GeneClean (Bio101) purified ClaI digested PCR product into the pDM138 unique ClaI site. The primers used were (HBV sequences are shown in lower case): 5′ primer 1151m (CGCGGATCCATCGATCttgctcggcaacggcctg) and 3′ primer 1582 (CGCGGATCCATCGATgcacacggtccggcagatga). Fragments were amplified by 30 cycles of PCR with p138(1151-1684) (HBV clone ATCC 31518) used as template. p138(1151-1684) designated HPRE1, p138(1151-1413) designated HPREα, and p138(1352-1684) designated 138HPREβ, have been previously described (20) .
HPRE point mutants were generated by PCR mutagenesis. The deletion mutants were generated by combining fragments from two point mutants introducing an SpeI site. p138(SpeI) was constructed by placing a double stranded linker with ClaI complementary ends (CGATGATCAGGCCTACTAGTACGCGTGAT and CGATCA-CGCGTACTAGTAGGCCTGATCATCG) into the unique ClaI site. Fragments cloned into p138(SpeI) were generated by PCR. The ∆HBVPRE surface expression vector (pSAg ∆RV) plasmid has been previously described (22) . The pSAg constructs were made by inserting the ClaI fragment relevant p138(1217-1582) plasmids into a ClaI digested pSAg ∆RV. All sequences were confirmed by sequencing.
Cells culture and transfections
The human kidney fibroblast line 293 was transfected for all assays. 293 cells were maintained in DMEM with 10% fetal calf serum and grown at 37_C. Approximately 24 h prior to transfection, 10 cm plates of confluent 293 cells were split 1:60 into 6-well plates or 1:8 into 10 cm plates. For CAT assays, 293 cells in 6-well plates were transfected with 0.5 µg of either a pDM138 reporter construct or pUC118, 0.2 µg of pCH110 (an SV40 β-Galactosidase reporter; 29) and 1.4 µg of pUC118. The HBV SAg assays were done with 2 µg of a pSAg reporter and 0.8 µg of CMV secreted alkaline phosphatase transfected into 293 cells in 6-well plates. Before each transfection, DNAs are checked for degradation state (fraction supercoiled), by visualization on an EtBr stained 1% agarose gel. The DNA and 12.4 µl of 2 M CaCl 2 were brought to a volume of 100 µl with 0.1 Tris-EDTA. While vortexing, 100 µl of 2 Hanks balanced salt solution was added dropwise. For northern analysis, 293 cells in 10 cm plates were transfected with 10 µg of reporter DNA (or pUC118) and 10 µg of pUC118. The DNA and 31 µl of 2 M CaCl 2 were brought to a volume of 250 µl with 0.1 Tris-EDTA. While vortexing, 250 µl of 2 Hanks balanced salt solution was added dropwise. The DNA/calcium phosphate mixture was added to the media. Approximately 10 h later fresh media was added. The cells were harvested ∼40 h later.
CAT assays
CAT assays were performed as previously described (20) . CAT assay transfections were performed in triplicate with separate calcium phosphate precipitations. An aliquot of each lysate was assayed for β-Galactosidase activity, which was then used to normalize each lysate for transfection efficiency. The normalized lysates were incubated at 37_C for 15 min to 1 h. Reaction volumes were 50 µl. Substrate and products were resolved by thin layer chromatography and quantitated using a PhosphorImager (Molecular Dynamics). The background activity of pDM138 was subtracted and the results expressed as a percentage of the positive control. The results are representative of at least three separate experiments. Typically, at least two different preparations of the test plasmid were assayed.
Surface antigen assay
The supernatant was harvested from the transfected cells and 10 µl were used for a secreted alkaline phosphatase assay, as previously described (22) . Expression of HBV SAg was determined by using 300 µl of the supernatant in the Abbott Labs Ausria II kit. Each transfection was done in triplicate. The SEAP results were used to normalize for transfection efficiency (30) . The background activity of pSAg∆RV was subtracted and compared as a percentage of expression of the positive control.
Northern analysis of RNA
293 cells were harvested using PBS, pelleted, washed twice with PBS, and one half of each sample was used for preparation of cytoplasmic and total RNA. Cells for total RNA were resuspended in 500 µl of a hypotonic buffer (10 mM potassium HEPES pH 7.8, 10 mM KCl, 50 µM Na 2 EDTA and 20% glycerol). Cells for cytoplasmic RNA preparation were resuspended in the above buffer with the addition of 0.5% NP-40. RNA was purified using the RNA Stat-LS protocol (Tel-Test). The RNA was precipitated, incubated with DNase for 15 min at 37_C, phenol extracted and precipitated. Ten µg of RNA were run on a 1% agarose/6.5% formaldehyde gel and transferred to a Duralon UV membrane (Stratagene). The probes were generated from a PCR product of the CAT gene of pDM138, which predominately detects unspliced RNA, and the SacI-EcoRV fragment of pCH110 (β-Gal).
Radiolabelling with [α-32 P]dCTP was performed using the Prime-It II kit (Stratagene). Blots were hybridized with probes in QuickHyb according to manufacturer's instructions (Stratagene).
Prediction of consensus structures
For prediction of consensus structures we used the tool ConStruct (31) . Shortly, the partition function of each viral RNA fragment was calculated at 50_C using RNAfold (32) . The RNA fragments used were taken from GenBank (release 1/97); they were equivalent to nucleotides 958-1590; individual fragments ranged in size from 593 to 631 nt. The fragments were aligned by ClustalW (33) and the resulting gaps introduced into the individual dot plots generated by RNAfold. Summation of the individual dot plots gives a consensus dot plot from which the consensus structure was extracted by maximizing the probability of base pairing. For the summation the following formula was used to suppress helices occurring only in few sequences with low probability:
where n denotes an individual sequence, M the total number of sequences, p n (i,j) the probability for pairing of nucleotides i and j in sequence n, and p c the consensus pairing probability.
Numbering of sequences
All sequence numbering presented is based on the following GenBank sequences: HBV, D00329; WHV, J02442; GSHV, K02716.
RESULTS
We have tested a series of deletions and mutants within the HPRE to identify and characterize regions important for HPRE activity. For our initial tests, we used the quantitative pDM138 assay (28, 29) . This well-characterized system is the commonly used assay to analyze the activity and function of the HPRE and the HPRE sub-elements (17, (19) (20) (21) 23 ). The reporter is derived from the second half of HIV-1, with the CAT gene (34) placed within the intron ( Fig. 2A) . Export of unspliced mRNAs is dependent on the presence of a functional HPRE, which can facilitate the cytoplasmic accumulation of unspliced mRNAs. When transiently transfected, the reporter mRNAs can be spliced, removing CAT, or exported into the cytoplasm unspliced, allowing the CAT gene to be translated. The CAT assay can be used to quantitate export activity of the element of interest. For the experiments described, each point was transfected in triplicate and normalized to a co-transfected β-Galactosidase internal control. The error bars represent the standard error of the mean (SEM). Results shown are representative of at least three independent experiments.
Defining the 3′-end of HPRE
In our initial characterization of the HPRE, the 3′ boundary was defined as nucleotide 1684. To further characterize the 3′ boundary of the HPRE, we generated a fragment encompassing nucleotides 1151-1582. This derivative, designated p138(HPRE2), was compared, by transient transfection of 293 cells, to a reporter construct containing nucleotides 1151-1684 of HBV and the α sub-element (HPREα; nucleotides 1151-1413) (Fig. 2B) . The results of the normalized CAT experiments are presented as activity relative to wild type. In this experiment, nucleotides 1151-1582 activated the pDM138 reporter to levels equivalent to the 1151-1684 fragment. HPREα activated the reporter to levels 34% of nucleotides 1151-1684. These results show that the fragment 1151-1582 contains the entire HPRE. In this HPREα study, mutational analysis of the α region was conducted in the context of the 1151-1582 fragment of HBV (HPRE2) while the analysis of the β region was conducted in the functionally equivalent context of nucleotides 1151-1684 (HPRE1). This was done to minimize potential folding disruptions near the 3′-end of the HPRE fragment while analyzing the HPREβ region. HPRE2 and HPRE1151-1684 are functionally equivalent.
Deletion analysis of HPRE
Deletions within the HPRE identify regions important for the activity of this element. The deletions were created by replacing the relevant nucleotides with an SpeI site (ACTAGT). A series of small deletions within the α sub-element was generated between nucleotides 1248 and 1347 of HBV in the context of HPRE2. Reporters containing each derivative were transiently transfected in 293 cells and compared to the full-length HPRE and HPREα (Fig. 2C) . The HPREα fragment is included as a control to define the function of a single HPRE sub-element. We used HPREα as a single sub-element control rather than HPREβ because HPREα includes the minimally active EnhI fragment which is present in the full-length derivatives.
Two deletions in the α region which reduced the activity of the HPRE to levels comparable to that of a single sub-element were identified (Fig. 2C) . Deletions of nucleotides 1272-1300 (∆2) and nucleotides 1295-1323 (∆3) had activities of 38 and 37%, respectively, when compared to the full-length HPRE. This activity was similar to that seen from HPREα, which activated the pDM138 reporter to 30% of HPRE2 and would indicate that the HPRE is not fully functional in either HPRE2(∆2) or HPRE(∆3). Two other deletion mutants, ∆1249-1277 (∆1) and ∆1318-1341 (∆4), functioned at levels closer to the HPRE2 fragment (76 and 78%, respectively). These results indicate that an important determinant for the function of HPREα is located between nucleotides 1277 and 1318 of HBV.
Deletions within the HPREβ region revealed a stretch of nucleotides required for full function (Fig 2D) . These deletions were created within the context of p138HPRE1 by replacing the deleted nucleotides with an SpeI site. p138HPRE1 was used as the full-length HPRE and positive control in these experiments. HPREα was used as the single sub-element control. A deletion of nucleotides 1382-1407 (∆5) had activity of ∼64% of the full-length element HPRE1. Another deletion, nucleotides 1402-1443 (∆6), exhibited similar activity (55%). The activities of the 1438-1463 (∆7) and 1458-1483 (∆8) deletions were 97 and 96% of the full-length HPRE, respectively. The single sub-element control, HPREα, had activity 32% of full-length. These data indicate that bases within nucleotides 1382-1437 are important for full HPRE activity.
HPRE fragments sufficient for function
Fragments of the HPRE which overlap the regions indicated important by the deletion analysis have PRE activity and are sufficient to activate the pDM138 reporter. We tested nucleotides 1278-1340 for function in the pDM138 assay (Fig. 3A) . These (1352-1684) . The background control for these experiments was p138(SpeI), which consists of pDM138 with an SpeI containing polylinker inserted into the unique ClaI site. One copy of HPRE1278-1340 had 40% of the activity of β. Two copies increased activity to 71% of p138(1352-1684) and three copies increased activity to 131%. These results indicate that nucleotides 1278-1340 are sufficient for function.
Two fragments overlapping the β sub-element are sufficient for function. These fragments nucleotides 1347-1457 (β1) and nucleotides 1442-1582 (β2). The β1 fragment 1347-1457, which includes the region indicated important by the deletion, was tested for activity in the pDM138 assay (Fig. 3B) . One copy of this fragment had 50% of the activity of p138(1352-1684), while the activity of two copies was 205% of β. The activity of p138(1442-1582) (β2) was 34% of β. Two copies of nucleotides 1442-1582 had an activity of 79% that of β in this assay. These β2 results are similar to those reported by Huang and Yen (21) . Multimerization of either nucleotides 1347-1457 or nucleotides 1442-1582 are able to activate pDM138 in a dose-dependent manner. The overlap of the regions identified by the deletion mutants (nucleotides 1277-1318 and 1382-1437) and fragments sufficient for function indicate determinants important for the function of the HPRE are located within nucleotides 1277-1318 and 1382-1437 of HBV.
HPRE contains two highly conserved stem-loops
In order to explore the possibility that PRE function is mediated through elements of secondary structure, we employed the ConStruct algorithm, which predicts the most stable structures common to multiple sequences (31) . The predicted most stable HPRE structure derived from 23 HBV variants is shown in Figure 4 . The greater the conservation of the base pair shown in Figure 4 , the darker the line between the two bases. These data reveal two stem-loops which are the most highly conserved structures common to all of the HBV variants tested. These structures were also repeatedly predicted by Mfold analysis of individual variants (data not shown) (35, 36) . We have designated nucleotides 1292-1321 as HSLα for stem-loop of HPREα. This stem-loop is within the 5′ region indicated by the deletions to be important for HPRE function in Figure 2C (nucleotides 1277-1318). The structure, derived from variant D00331, shown in Figure 5A , has a loop of 5 nt and a single mismatched G 1301 nucleotide located four bases from the loop end of the structure. Stem-loop α is also predicted to occur in WHV (WSLα) (Fig. 5B) . The second structure, HBV stem-loop β1 (HSLβ1), nucleotides 1410-1434, is a 25 nt stem-loop which contains a 9 nt loop (Fig. 6A) . This stem-loop is contained within the 3′ region (nucleotides 1382-1437) indicated important for HPRE function (Fig. 2D) . HSLβ1 is also predicted in WHV (WSLβ1) (Fig. 6B) . A secondary structure that is conserved to a degree similar to that of HSLα and HSLβ1 is not obvious within the β2 (HPREβ2) region. The two most conserved HPRE structures are predicted to be contained in regions which are sufficient for HPRE function, nucleotides 1278-1340 and nucleotides 1388-1457 (Fig. 3) .
HPREα stem-loop
The conservation and phylogenetic covariations of the stem-loop structures between several different variants of HBV, WHV, Ground Squirrel Hepatitis Virus (GSHV) and Arctic Squirrel Hepatitis Virus (ASHV) were explored to determine if these structures are significant. Several covariations can be found in HBV variants which maintain the integrity of HSLα (Fig. 5) . A covariation is a set of mutations which always occur as a group and do not affect secondary structure or function. Two co-varying base pairs within a putative stem structure is considered evidence that a structure exists in vivo (37) . An example of a co-variation can be found in HBV variant accession number X69798, which has a U 1296 -A 1317 base pair, found in most HBV variants, (Fig. 5C ) changed to a C 1296 -G 1317 base pair, along with the loss of the base pairing interactions at the bottom of the stem. Additionally, an A 1314 G (A 1314 changed to G) mutation is seen in the strains X65259 and D00330. This change would not effect this secondary structure because it would generate a stable U 1299 -G 1314 base pair at this position.
More pronounced examples of co-variation can be seen when comparing the HSLα sequence to the WHV and GSHV sequences (Fig. 5C ). Although 8 nt vary between HBV and WHV in the 25 nt that make up the stem region of this structure (co-variations 1, 2 and 3 in Fig. 5A , B and C), the overall stem-loop structure formed is virtually identical (Fig. 5B) . Additionally, a co-variation can be seen between WHV and GSHV where a C 1428 -G 1443 base pair is replaced with an A 1428 -U 1443 interaction (Fig. 5C) . Comparison of HBV, WHV and GSHV sequences also reveals conservation within the loop. Two of the five nucleotides in the loop region of SLα (G 1307 and G 1308 in HBV; G 1437 and G 1438 in WHV, GSHV) are absolutely conserved across HBV, WHV and GSHV and that one nucleotide varies in only a single HBV strain (nucleotide 1305 in HBV strain X01587) (Fig. 5C ). The fifth position of the loop is always U 1309 in HBV and A 1439 in WHV/GSHV. The most variable of the loop bases is nucleotide 1306 in HBV (nucleotide 1436 in WHV), which is an A or C in HBV and a U in WHV/GSHV. The conservation of HSLα and the presence of the co-variations between HBV and WHV/GSHV are indicators that the stem-loop is an in vivo structure and that HSLα is potentially important for HPRE function. 
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HPREβ1 stem-loop
The HSLβ1 stem is highly conserved within the HBV strains and throughout the different mammalian Hepadnaviruses. Only one position within this stem varies in the 23 HBV strains examined (Fig. 6B) . In strain HBV M54293, C 1431 is changed to a U. This variant changes a G-C pair to a G-U pair, which should have no effect on the integrity of the stem. There is no additional variation seen within the WHV and GSHV strains in the stem region of SLβ1 (Fig. 6) . The SLβ1 stem is a very highly conserved region between HBV, WHV and GSHV.
The nine loop nucleotides of SLβ1 (Fig. 6B ) are highly conserved within the different species of virus, but are not as conserved between the different Hepadnaviruses as is the stem. Loop nucleotides U 1419 , U 1420 and U 1425 are absolutely conserved. Nucleotides C 1417 and C 1418 each vary in only a single strain, HBV M38636 and ASHV U29144, respectively. The sequence U 1421 GU is found in the HBV strains while the sequence in WHV and GSHV strains is CUG. Only position 1424 is variable, and in all strains this residue is a pyrimidine. Despite the sequence specific differences, all of the SLβ1 loop sequences each contain only a single purine. The extreme sequence conservation of SLβ1 between Hepadnaviruses indicates that it is a real structure and may be important for PRE function.
Co-variation analysis revealed one potential base pair within the β2 region. This co-variation is located at positions 1477 and 1485 of HBV. This potential base pair is not present in the ConStruct prediction (Fig. 4) . Because of the lack of RNA structures conserved to the extent of HSLα and HSLβ1 with possible corresponding co-variations we did not analyse the β2 region further in this study.
HSLα and HSLβ1 are required for HPRE function
The structural conservation, covariation and deletion analyses provided compelling evidence that the HSLα and HSLβ1 structures have been conserved as the different mammalian Hepadnaviruses diverged. The conservation suggests an important role for these secondary structures in viral replication. Here we show a series of stem disruption and compensatory mutations which confirm that these structures are required for full HPRE activity.
A series of stem mutants show that the presence of intact HSLα and HSLβ1 stems are important for full HPRE function. HSLα mutant M11 changes nucleotides 1295-1300 to an SpeI site (ACTAGT) and is predicted to disrupt the integrity of the stem (Fig. 7A) . Two HSLα mutants based on HBV/WHV co-variations 1 and 2 (Fig. 5A , B and C) were generated which would first disrupt and then restore the stem structure of HSLα. M23, which changes U 1299 C and A 1303 U, disrupts two base pair interactions within the stem of HSLα (Fig. 7A) . The second mutant, M23c, contains four changes which complete the co-variations: U 1299 C, A 1303 U, U 1311 A and A 1314 G. This series of changes restores the base-pairing disrupted by M23, reconstituting the HSLα stem. Figure 7A shows the results of a pDM138 assay of the HSLα stem mutants. M11 had activity 53% of the full-length HPRE. The M23 mutation also had a significant effect on HPRE function, reducing activity to 41% of the wild-type fragment, compared to 35% of wild-type seen from the single sub-element control (p138HPREα). However, the M23c mutant, which is designed to restore the integrity of the HSLα structure, had an activity 90% of the wild-type. These results indicate that the intact stem of HSLα is required for the function of HPRE and that the bases altered in M23 and M23c are paired in the active secondary structure.
Stem mutations of HSLβ1 (nucleotides 1408-1437) show that an intact HSLβ1 stem is also important for HPRE function (Fig. 7B) . A deletion mutant, HPRE∆1418-1443, eliminates the loop and 3′ side of the stem. Mutant M30 replaces G 1411 GG with C 1411 CC, which is predicted to disrupt three G-C base pairs and destabilize the stem. A compensatory mutant, M30c, was created to repair the changes to the stem in M30. The M30c mutant contains the G 1411 GG to C 1411 CC change as well as a C 1431 CC to G 1431 GG mutation and is predicted to restore the integrity of the stem. The results of a pDM138 assay of the HSLβ1 stem mutants are shown in Figure 7B . The activity of the 1418-1443 deletion was 45% that of the wild-type HPRE. The stem mutant, M30, had 47% of the activity of the full-length HPRE, while the compensatory mutant, M30c, had 88% of the activity of wild-type. The ability to repair the stem with a compensatory mutation shows that the integrity of the stem, not the specific sequence of the stem, is important for pDM138 activation. The requirement for intact stems HSLβ1 and HSLα for full HPRE function indicates the importance of secondary structures in HPRE function.
The presence of an enhancer does not affect HPRE function
A HPRE mutant in which both HSLα and HSLβ1 are deleted shows that these stem-loops are independent and not functionally A B C redundant (Fig. 8 ). This mutant was tested in the context of nucleotides 1217-1582 (HPRE3). This context allows confirmation that sequences overlapping the enhancers are not necessary for HPRE function and that minimal enhancer functionality has no effect on the relative activity of the HPRE mutants.
Results of the HPRE3 mutants tested in the pDM138 assay are shown in Figure 8B . All of the previous studies with the full-length HPRE have included either one or both of the enhancers (17) (18) (19) (20) (21) , usually in a cell line where they are fully active. p138(1217-1582 ∆1295-1323) had activity of 24% of wild-type (p138HPRE3) while p138HPRE(∆6) had activity 53% of wild-type. The double A B C deletion p138HPRE3(∆3:∆6) had an activity only 13% of wild-type, an activity less than p138HPRE3α (24% of wild-type) and p138HPREβ (20% of wild-type). These results suggest that HSLα and HSLβ1 act cooperatively and they are not functionally redundant. The remaining activity present in the double deletions can be ascribed to the third region of activity, β2 (Fig. 2D ). These data suggest that HPRE functionality does not overlap the enhancer sequences and that the enhancer function does not alter the relative activity of the HPRE mutants.
A northern blot of p138HPRE3 constructs confirm that the reduction in activity in the pDM138 system is due to a reduction in the amount of unspliced cytoplasmic transcripts from which CAT can be expressed. Figure 8C is a northern blot of cytoplasmic RNA probed for β-Gal and CAT. The β-Gal signal, derived from a co-transfected plasmid (pCH110) and used to normalize loading, shows equivalent loading. The CAT probe reveals all messages which could lead to CAT expression. Figure 8C shows 
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that the CAT gene is only present in unspliced transcripts. The CAT signal of the wild-type HPRE3 has the most activity and HPRE3α has a reduced signal when compared to wild type. The signal from the p138HPRE3(∆3:∆6) construct is lower than that of HPRE3α in both the cytoplasmic and total fractions. These results correlate with the CAT results from these constructs, indicating that pDM138 CAT activity observed is due to the cytoplasmic accumulation of unspliced transcripts.
HSLα and HSLβ1 mutants have similar function in an HBV surface antigen (SAg) assay
To confirm the results of the HPRE mutants in a more natural context, we used the intronless HBV SAg expression assay. This assay, although more variable, gives results similar to the pDM138 assay. This system uses an HBV SAg expression vector in which EnhI, EnhII and the HPRE have been removed (Fig. 9A) . HPRE3 derivatives are placed into a unique ClaI site contained within the intronless HBV SAg message. The HBV SAg expression vector and a secreted alkaline phosphatase expression vector were co-transfected into 293 cells and the supernatants assayed for activity. The SEAP assay was used to normalize for transfection efficiency and HBV SAg expression was quantitated. The results are shown in Figure 9B as a percentage of wild-type activity. The HSLα and HSLβ1 deletions, pSAgHPRE3(∆3) and pSAgHPRE3(∆6) had reduced activities compared to wild-type, 40 and 70% respectively. The double deletion, pSAgHPRE3(∆3:∆6) had an activity of 24%, while pSAgHPRE3α had an activity of 34%. The activities of these small deletions are similar to previously published results from the gross HPRE deletion analysis analyzed with a surface reporter (17, 18) . The stem and compensatory mutants show that the integrity of the HSLα and HSLβ1 stems are required for full HPRE function. The M23 and M30 stem mutants have reduced activity, 64 and 63% respectively, while the compensatory mutants function is equivalent the full length HPRE (pSAgHPRE3). The activity of pSAgHPRE3(M23c) was 99% while pSAgHPRE3(30c) had an activity of 102% These results show that HSLα and HSLβ1, and the integrity of the stems, are required for full PRE activity in the intronless HBV SAg expression system. 
A B C DISCUSSION
The HPRE allows cytoplasmic accumulation of unspliced transcripts, possibly via direct nuclear export (17) (18) (19) 23) . Initial characterization revealed that this RNA element consists of at least two independent sub-elements within bases 1151-1684, each of which are likely to contain a binding site for a cellular factor. Here we show that the minimal HPRE, encompassing nucleotides 1217-1582 of HBV, contains three distinct regions of activity, two of which contain a highly conserved stem-loop structure which is necessary for full HPRE activity.
The three regions within nucleotides 1217-1582 (HPRE1278-1340, HPRE1388-1457, HPRE1442-1582) are independently sufficient to activate pDM138 in a dose-dependent manner. Huang and Yen (21) reported that they could detect some dose-dependent pDM138 activation from multimerization of fragments containing HPREα, HPREβ1 fragments. The lower activation detected for these fragments may have been due to the choice of fragment boundaries and resulting folding effects. The HPRE1278-1340 and HPRE1388-1457 each contain one of the most conserved structures common to the HPRE, HSLα and HSLβ1. Both of these structures are contained within a larger folded structure of nucleotides 1226-1444 (Fig. 4) . This core structure, as predicted by the ConStruct algorithm, contains both HSLα and HSLβ1 but not HPREβ2. HSLα is highly conserved and contains four positions which co-vary in the 11 bp stem of SLα in the mammalian Hepadnaviradae (Fig. 5) . Two co-varying base pairs within a putative stem-loop structure is considered evidence that a structure exists in vivo (37) . Sequence conservation in the stem structure of SLβ1 between HBV, WHV and GSHV is nearly absolute (Fig. 6) . Due to the lack of sequence variation, even between HBV, WHV and GSHV, no co-variations occur. The third region of activity (HPREβ2) does not contain a conserved stem-loop structure. This region of the HPRE is variable (data not shown).
A series of HPRE mutants shows that HSLα and HSLβ1 are real and necessary for HPRE function. Mutants designed to disrupt the predicted RNA stem-loop structures (M11, M23 and M30) significantly reduced activity, while compensatory mutants (M23c and M30c), which repair the base pairing of the stems, restored function (Fig. 7) . The magnitude of the effect of the stem mutants was similar to the previously observed effects of large deletions of the HPRE (17, 20, 21) . The results of the HBV SAg expression assay confirm these results in a more natural context. These data, along with the conservational and co-variation data, indicate that the stem structures are present within the folded structure of the in vivo HPRE and that their integrity is important for HPREα and HPREβ function. The requirement for HSLα and HSLβ1 suggests that function is mediated through secondary structure. The ability of a
